Bromocriptine mesylate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bromocriptine mesylate and what is the scope of patent protection?
Bromocriptine mesylate
is the generic ingredient in three branded drugs marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Ss Pharma, Aurobindo Pharma Usa, Padagis Us, Sandoz, and Veroscience, and is included in eight NDAs. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.Bromocriptine mesylate has thirty-one patent family members in thirteen countries.
There are eight drug master file entries for bromocriptine mesylate. Eight suppliers are listed for this compound.
Summary for bromocriptine mesylate
International Patents: | 31 |
US Patents: | 12 |
Tradenames: | 3 |
Applicants: | 8 |
NDAs: | 8 |
Drug Master File Entries: | 8 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 6 |
Patent Applications: | 5,197 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for bromocriptine mesylate |
What excipients (inactive ingredients) are in bromocriptine mesylate? | bromocriptine mesylate excipients list |
DailyMed Link: | bromocriptine mesylate at DailyMed |
Recent Clinical Trials for bromocriptine mesylate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Case Western Reserve University | Phase 1/Phase 2 |
Andrew Moshfeghi, MD, MBA | Phase 1/Phase 2 |
VeroScience | Phase 1 |
Pharmacology for bromocriptine mesylate
Drug Class | Ergot Derivative |
Medical Subject Heading (MeSH) Categories for bromocriptine mesylate
US Patents and Regulatory Information for bromocriptine mesylate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Padagis Us | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | TABLET;ORAL | 077646-001 | Oct 1, 2008 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Zydus Pharms Usa Inc | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | CAPSULE;ORAL | 078899-001 | Jul 30, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for bromocriptine mesylate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ss Pharma | PARLODEL | bromocriptine mesylate | CAPSULE;ORAL | 017962-002 | Mar 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for bromocriptine mesylate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2010256366 | Combination of dopamine agonists plus first phase insulin secretagouges for the treatment of metabolic disorders | ⤷ Try a Trial |
Mexico | 2019003619 | FORMULACIONES DE BROMOCRIPTINA. (BROMOCRIPTINE FORMULATIONS.) | ⤷ Try a Trial |
Uruguay | 34776 | FORMULACIONES DE BROMOCRIPTINA | ⤷ Try a Trial |
Hong Kong | 1208173 | 溴麥角環肽製劑 (BROMOCRIPTINE FORMULATIONS) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.